Emerging Molecularly Targeted Radiation Agent Facilitates Bone Marrow Transplant in Patients with Acute Myeloid Leukemia
Diagnostic Imaging
JUNE 26, 2023
A new modality that provides high-dose, molecularly targeted radiation to hematopoietic cells allows bone marrow transplant in patients with relapsed or refractory acute myeloid leukemia (AML) and may double one-year survival rates in comparison to conventional care, according to new research that garnered “Abstract of the Year” honors at the Society (..)
Let's personalize your content